Good scientists reveal how they do their experiments and report their results; so should any machine-driven research ...
Mouse and human data hint that biological differences may shape drug bioavailability in ways clinical trials often overlook ...
C&EN business editor Michael McCoy, at m_mccoy@acs.org. The activist investor Ancora Holdings is pushing Ashland to put itself up for sale. Ashland was once a diversified chemical giant, but ...
Our contributor recalls his first international collaboration and how tools of communication have changed in an increasingly ...
Lithium has reigned in the battery world for decades. Researchers have tried for years to make a cheaper, more sustainable successor to lithium-ion batteries by using the element’s more common ...
Just 6 months into the job, GSK’s CEO is spearheading some big moves. The London-based pharma giant announced Tuesday that it ...
The US is getting a new sunscreen ultraviolet (UV) filter for the first time in 30 years. On June 9, the US Food and Drug ...
Developing such currencies and providing ways for all our members and community associates—more than 260,000 of them ...
The work proves that embryo editing is far from a clinical reality. But the experiment has sparked controversy nonetheless ...
Under pressure from activists and state environmental authorities, Freepoint Eco-Systems has suspended operations at its new ...
You might be asked to stand up on conference calls, for example, because AI video avatars don't have legs. That was one ...
Fifteen years ago, physicists worked out a method to increase image contrast by hitting the electron imaging beam with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results